|
|
Biopharma 4.0 encompasses several key innovations, including the widespread automation of business processes within a company, comprehensive data integration, and data interoperability between manufacturing and operations. By collectively pursuing the central tenets of Biopharma 4.0, the biopharma industry can realize gains that may increase speed-to-market and agility, and support the sector’s continued growth.
|